We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Accelerate Diagnostics in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $2.08K → $0 (-$2.08K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BC
Birchview Capital
Vermont
-$2.08K
2
BCWM
Bartlett & Co Wealth Management
Ohio
-$1

AXDX Hedge Fund Activity: Q3 2025 in Review

0 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2025, worth a combined $0 — down 100% from $2.08K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AXDX and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Birchview Capital, exiting entirely with an estimated $2.08K sold.

  • 0 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2025, down from 3 in Q2 2025.
  • Funds reported $0 of Accelerate Diagnostics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Accelerate Diagnostics positions in Q3 2025 and 3 closed out, a net change of -3 holders.
  • The largest Accelerate Diagnostics seller in Q3 2025 was Birchview Capital, an estimated $2.08K sold.

Based on aggregated 13F filings for Q3 2025.